• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
INTI

INTI

Inhibitor Therapeutics, Inc.

OTCHealthcareBiotechnologyUS

USD0.08

+0.00 (+0.00%)

Rating:C+

Company Profile

CEO

Francis E. O'Donnell Jr.

IPO Date

2013-09-13

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.09

Prev. Close

$0.08

Day Low

$0.08

Day High

$0.09

52W Low

$0.04

52W High

$0.12

Market Cap

$0.01B

Volume

0.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Insider Trades
FiledInsiderRoleTypeA/DSharesPrice
1 Jun 2026Vasisht NirajdirectorA-AwardAcquired50,000$0.00
10 Apr 2025Vasisht NirajdirectorA-AwardAcquired
50,000
$0.00
7 Apr 2025SEARS SAMUEL P JRdirectorA-AwardAcquired50,000$0.00
19 Feb 2025MCNULTY JAMES AofficerDisposed0$0.00
16 May 2024MCNULTY JAMES A10 percent owner, officer: CHIEF FINANCIAL OFFICERA-AwardAcquired100,000$0.08
16 May 2024SEARS SAMUEL P JRdirectorA-AwardAcquired50,000$0.00
17 May 2023MCNULTY JAMES A10 percent owner, officer: See RemarksJ-OtherAcquired20,101,057$0.00
17 May 2023MCNULTY JAMES A10 percent owner, officer: See RemarksJ-OtherAcquired398,135$0.00
17 May 2023MCNULTY JAMES A10 percent owner, officer: See RemarksJ-OtherDisposed79,627,069$0.00
22 Dec 2022Vasisht Niraj—Disposed——